Selective FLT3 inhibition of FLT3-ITD+ acute myeloid leukaemia resulting in secondary D835Y mutation: a model for emerging clinical resistance patterns.
第一作者:
A S,Moore
第一单位:
Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, Sutton, UK.
作者:
医学主题词
动物(Animals);细胞凋亡(Apoptosis);苯磺酸盐类(Benzenesulfonates);苯并噻唑类(Benzothiazoles);印迹法, 蛋白质(Blotting, Western);细胞周期(Cell Cycle);细胞增殖(Cell Proliferation);抗药性, 肿瘤(Drug Resistance, Neoplasm);女(雌)性(Female);人类(Humans);咪唑类(Imidazoles);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);小鼠(Mice);小鼠, 裸(Mice, Nude);突变(Mutation);烟酰胺(Niacinamide);苯脲化合物(Phenylurea Compounds);哌嗪类(Piperazines);蛋白激酶抑制剂(Protein Kinase Inhibitors);吡啶类(Pyridines);喹唑啉类(Quinazolines);串联重复序列(Tandem Repeat Sequences);肿瘤细胞, 培养的(Tumor Cells, Cultured);fms样酪氨酸激酶3(fms-Like Tyrosine Kinase 3)
DOI
10.1038/leu.2012.52
PMID
22354205
发布时间
2025-05-29
- 浏览40
Leukemia
1462-70页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



